Sequencing Consumables Market Analysis
Based on product type, the market is segmented into kits, reagents, accessories. The kits segment is poised for significant growth at a CAGR of 22.4% during the forecast period. Moreover, the kit segment is further bifurcated into DNA library preparation, RNA library preparation, purification & quality control, library quantification, target enrichment, and other kit types.
- With the increasing interest in single-cell omics, there has been a rise in the availability of single-cell sequencing kits. These kits are designed to support the isolation, preparation, and sequencing of individual cells, enabling researchers to explore cellular heterogeneity and uncover insights not possible with bulk sequencing.
- As laboratories seek to increase throughput and efficiency, there is a trend toward sequencing kits that are compatible with automated liquid handling systems. Automation can streamline workflows, reduce manual errors, and enhance reproducibility. Thus, such aforementioned factors will drive the market expansion.
Based on platform, the market is segmented into 1st, 2nd, and 3rd generation. The 2nd generation segment accounted for a revenue share of 80.4% in 2023 and is estimated to follow similar trend over the coming years.
- NGS technologies, including Illumina sequencing, have been the primary drivers of the sequencing consumables market for over a decade. Illumina sequencing platforms are known for their high throughput, allowing researchers to generate large amounts of sequencing data in a relatively short time.
- The cost-effectiveness of Illumina sequencing has made it widely accessible to researchers, enabling a broad range of applications from small-scale projects to large-scale genomics initiatives.
- It has been widely adopted across various research domains, including spatial genomics and transcriptomics, epigenomics, and metagenomics. The versatility of Illumina platforms has contributed to their popularity among researchers conducting diverse experiments and studies.
Based on application, the sequencing consumables market is segmented into clinical diagnostics, forensic diagnostics, pharmacogenomics, agrigenomics and other applications. The clinical diagnostics segment is further divided into cancer diagnostics, infectious disease diagnostics, reproductive health, and other clinical applications. The clinical diagnostics segment is poised for significant growth at a CAGR of 23% during the forecast period.
- Cancer genomics has emerged as a major application within clinical diagnostics. Sequencing technologies are employed to analyze the genomic alterations in tumors, facilitating the identification of targeted therapies.
- Molecular diagnostics based on genomics play a crucial role in cancer diagnosis, prognosis, and treatment selection.
- Furthermore, sequencing technologies are employed in the detection and characterization of infectious agents, contributing to the diagnosis and monitoring of infectious diseases. NGS is utilized for pathogen identification, antimicrobial resistance profiling, and epidemiological studies.
The market by end-use is categorized into pharmaceutical and biotechnology companies, hospitals and laboratories, academic research institutes, and other end-users. The academic research institutes segment accounted for around USD 3.1 billion revenue size in 2023.
- Academic research institutes play a crucial role in advancing genomic research and developing new sequencing methodologies. They contribute to basic research, innovation, and the training of future scientists. Genomic studies across various disciplines, including genetics, molecular biology, evolutionary biology, and environmental genomics.
- A broad range of sequencing consumables to support diverse research projects, from fundamental genomics studies to specialized applications such as single-cell sequencing.
- Genetics is a core focus of academic genomics research. Institutes explore heredity, gene expression, and the inheritance of traits, contributing to the understanding of how genes influence biological processes and contribute to genetic disorders.
- Their contributions not only advance the understanding of genetics and molecular biology but also have broader implications for medicine, agriculture, ecology, and beyond.
North America market accounted for USD 3.2 billion revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
- Companies in North America involved in sequencing consumables have engaged in strategic partnerships and collaborations to expand their product offerings and market presence.
- Government initiatives supporting genomics research and precision medicine have contributed to the growth of the sequencing consumables market.
- Funding for large-scale genomics projects and initiatives focused on genomic data collection has increased the demand for consumables.
- Next generation sequencing technologies, including platforms from companies such as Illumina, have experienced rapid adoption in North America. The demand for consumables compatible with NGS platforms has grown as these technologies become more prevalent in research, clinical diagnostics, and various applications.